March Medicaid Madness
The Host With Medicare and Social Security apparently off the table for federal budget cuts, the focus has turned to […]
» Read moreHome »
FDA Grants Accelerated Approval to Filspari (sparsentan) for the Reduction of Proteinuria in IgA Nephropathy First single molecule Dual Endothelin […] TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE) February 17, 2023 — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries […] FDA Approves Brenzavvy (bexagliflozin) for the Treatment of Adults with Type 2 Diabetes The FDA approval is based on results […] For drugmaker Pfizer, a fortune amassed in the covid pandemic is now paving the path to pharma nirvana: a weight […] New research indicates politics may be a matter of life or death. A study published June 7 by the BMJ […] Can’t see the audio player? Click here to listen on Acast. You can also listen on Spotify, Apple Podcasts, Stitcher, […] With time running out in the 2022 legislative session, Georgia lawmakers took up a bill to regulate raw milk. An […] If there has been a silver lining to this terrible covid-19 pandemic, it is that the rate of Americans without […] SACRAMENTO — With access to abortion at stake across America, California is preparing to become the nation’s abortion provider. Democratic […]
FDA Grants Accelerated Approval to Filspari
Teva Announces FDA Approval of Austedo XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of Austedo
FDA Approves Brenzavvy
Pfizer’s Covid Cash Powers a ‘Marketing Machine’ on the Hunt for New Supernovas
A Deep Dive Into the Widening Mortality Gap Across the Political Aisle
KHN’s ‘What the Health?’: Waking Up to Baby Formula Shortage
As Overdoses Soar, More States Decriminalize Fentanyl Testing Strips
The End of the Covid Emergency Could Mean a Huge Loss of Health Insurance
California Plans for a Post-Roe World as Abortion Access Shrinks Elsewhere
